- cafead   Aug 19, 2022 at 10:42: AM
via CureVac has initiated the Phase I clinical trial of the modified Covid-19 messenger ribonucleic acid (mRNA) vaccine candidate CV0501, to be given as a booster following the initial vaccine series.
article source
article source